Pain News and Research

Latest Pain News and Research

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

29 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

Researchers confirm for the first time that achalasia is autoimmune in origin

Achalasia is a rare disease - it affects 1 in 100,000 people - characterized by a loss of nerve cells in the esophageal wall.

29 Jul 2014

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

Sufferers of Chronic Fatigue Syndrome are set to benefit with the dual launch of a specialist Griffith University clinic and smartphone app, both aimed to manage their illness and improve health outcomes.

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

Viewpoints: GOP's 'political sideshow;' Boehner says House must defend the constitution; Jonathan Gruber on center stage about subsidies

This week, before the House leaves for its August recess, the GOP majority is expected to approve a lawsuit against Obama.

29 Jul 2014

Non-endoscopic procedure effective in treating severe chronic migraine headaches

A revised version of a surgical procedure to treat severe chronic migraine headaches led to significant symptom relief more than 90 percent of the time in patients treated at Massachusetts General Hospital.

29 Jul 2014

Opioid use does not impair reverse shoulder arthroplasty success

Taking opioids prior to reverse shoulder arthroplasty does not hamper patients’ chances of having successful outcomes, researchers have found.

28 Jul 2014

Astute Medical, OCD partner to expand access to new acute kidney injury test

Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.

From Ortho-Clinical Diagnostics, Inc. 28 Jul 2014

Timely diagnosis and treatment important to combat juvenile arthritis

Most people associate arthritis with aging, but the fact is, one in 1,000 children is diagnosed with juvenile arthritis.

27 Jul 2014

Minister Ambrose calls for proposals to tackle prescription drug abuse

The Honourable Rona Ambrose, Minister of Health, today issued a national Call for Proposals to improve the prescribing practices for prescription drugs that have a high risk of abuse or addiction.

26 Jul 2014

Massage therapy can alleviate symptoms of multiple sclerosis

An estimated 2.3 million people worldwide live with multiple sclerosis (MS) each day, a debilitating disease that can often cause severe pain, muscle spasms, poor circulation, anxiety, stress and clinical depression.

26 Jul 2014

Trials show immunizations are effective in adults

As kids prepare to head back to school, required immunizations are typically on the to-do list, but getting potentially lifesaving vaccines should not end when adulthood begins, says one University of Alabama at Birmingham infectious diseases expert.

26 Jul 2014

Bay Area Pain Medical Associates issues notification related to security, protection of medical records

On May 19, 2014, the medical office of Bay Area Pain Medical Associates was broken into and many items were stolen including three desktop computers.

26 Jul 2014

Study investigates ventilation strategies used during anaesthesia given for abdomen surgery

A multi-centre study at 30 centres across Europe, North and South America involving a total of 900 test subjects has investigated various ventilation strategies currently used during anaesthesia given for surgical procedures involving the abdomen to see just how effective they are.

26 Jul 2014

Clinical judgement with ECG and blood test effective in reducing hospital admissions for chest pain

Clinical judgement, combined with an electrocardiogram (ECG) and blood test on arrival, is effective in reducing unnecessary hospital admissions for chest pain, a new study shows.

From The University of Manchester 26 Jul 2014

FDA issues Complete Response Letter for AcelRx's Zalviso NDA

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Company's new drug application (NDA) for Zalviso (sufentanil sublingual tablet system).

26 Jul 2014

EMA recommends full marketing approval for IMBRUVICA in the European Union

Pharmacyclics, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion recommending the granting of full marketing approval for IMBRUVICA (ibrutinib) in the European Union.

25 Jul 2014

Biogen Idec receives marketing authorization from EC for multiple sclerosis drug

Today Biogen Idec announced that the European Commission (EC) has granted marketing authorization for PLEGRIDY (peginterferon beta-1a) as a treatment for adults with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS).

25 Jul 2014

Longer looks: the economics of infertility; placebos as treatment raises ethical dilemmas

About a decade ago, Medicaid programs were struggling to keep up with skyrocketing prescription drug costs. Between 1997 and 2002, drug spending in the program for low-income Americans grew by about 20 percent annually. ... Medicaid directors began looking for ways to tamp down on those costs. One of the most popular policies was something called "prior authorization" for a new wave of more expensive, anti-psychotic drugs ,... These policies, in a sense, worked: they helped rein in how much Medicaid spent filling prescriptions. But in another sense, they may not have worked at all: a growing body of research has begun questioning whether restricting drug spending may have just shifted costs elsewhere - particularly, into the prison system (Sarah Kliff, 7/22).

25 Jul 2014

Pain News and Research

Latest Pain News and Research

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

Researchers confirm for the first time that achalasia is autoimmune in origin

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Viewpoints: GOP's 'political sideshow;' Boehner says House must defend the constitution; Jonathan Gruber on center stage about subsidies

Non-endoscopic procedure effective in treating severe chronic migraine headaches

Opioid use does not impair reverse shoulder arthroplasty success

Astute Medical, OCD partner to expand access to new acute kidney injury test

Timely diagnosis and treatment important to combat juvenile arthritis

Minister Ambrose calls for proposals to tackle prescription drug abuse

Massage therapy can alleviate symptoms of multiple sclerosis

Trials show immunizations are effective in adults

Bay Area Pain Medical Associates issues notification related to security, protection of medical records

Study investigates ventilation strategies used during anaesthesia given for abdomen surgery

Clinical judgement with ECG and blood test effective in reducing hospital admissions for chest pain

FDA issues Complete Response Letter for AcelRx's Zalviso NDA

EMA recommends full marketing approval for IMBRUVICA in the European Union

Biogen Idec receives marketing authorization from EC for multiple sclerosis drug

Longer looks: the economics of infertility; placebos as treatment raises ethical dilemmas

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in